Etiology of bacterial infections in febrile neutropenic patients: The role of the laboratory in the diagnosis;Étiologie des infections bactériennes chez les patients neutropéniques fébriles: Rôle du laboratoire dans le diagnostic

Presse Medicale

Volumn 33, Issue 7, 2004, Pages 460-466

  Poyart, Claire ^a   Morand, Philippe ^a   Buzyn, Agnès ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; BACTEREMIA; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIAL STRAIN; BLOOD CULTURE; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CEREBROSPINAL FLUID ANALYSIS; COAGULASE NEGATIVE STAPHYLOCOCCUS; COMORBIDITY; ENTEROBACTERIACEAE; ESCHERICHIA COLI; FEBRILE NEUTROPENIA; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HOSPITAL INFECTION; HUMAN; INCIDENCE; KLEBSIELLA; LABORATORY DIAGNOSIS; MORTALITY; PNEUMONIA; PSEUDOMONAS AERUGINOSA; REVIEW; SCREENING; SEPTICEMIA; STAPHYLOCOCCUS AUREUS; SUPERINFECTION; URINALYSIS; BACTERIAL PNEUMONIA; CROSS INFECTION; FRANCE; GRAM NEGATIVE INFECTION; MICROBIOLOGICAL EXAMINATION; MULTIDRUG RESISTANCE; NEUTROPENIA; OPPORTUNISTIC INFECTION;

BACTEREMIA; BACTERIOLOGICAL TECHNIQUES; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE; FRANCE; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; NEUTROPENIA; OPPORTUNISTIC INFECTIONS; PNEUMONIA, BACTERIAL;

EID: 1842842308     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0755-4982(04)98633-2     Document Type: Review

References (40)

1. Bodey GP. Infections in cancer patients. Cancer Treat Rev 1975; 2: 89-128.
2. Oppenheim BA. The changing pattern of infection in neutropenic patients. J Antimicrob Chemother 1998; 41: 7-11.
3. Zinnner SH. Changing epidemiology of infections in patients with neutropenia and cancer: emphasis of Gram-positive and resistant bacteria. Clin Infect Dis 1999; 29: 490-4.
4. Schimpff SC, Satterlee W, Young VM, Serpick A. Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia. N Engl J Med 19971; 204: 1061-5.
5. EORTC and I. A. T. C. Group. Gram-positive bacteremia in granulocytopenic cancer patient. Eur J Cancer 1990; 25: 569-74.
6. Bochud PY, Eggiman PH, Clandra T, Van Melle G, Saghafi L, Francoli P. Bacteremia due to viridans streptococcus in neutropenic patients with cancer: clinical spectrum and risk factors. Clin Infect Dis 1994; 18: 25-31.
7. Pfaller MA, Herwald LA. Laboratory, clinical and epidemiological aspects of coagulase-negative staphylocci. Clin Microb Rev 1998; 1: 281-99.
8. Herwaldt LA, Hollis RJ, Boyken LD, Pfaller MA. Molecular epidemiology of coagulase-negative staphylococci isolated from immunocompromised patients. Infect Control Hosp Epidemiol 1992; 13: 86-92.
9. Wade JC, Schimpff SC, Newman KA, Wiernik PH. Staphylococcus epidermidis: an increasing cause of infection in patients with granulocytopenia. Ann Intern Med 1982; 97: 503-8.
10. Souli M, Giamarellou H. Effects of slime produced by clinical isolates of coagulase-negative staphylococci on activities of various antimicrobial agents. Antimicrob Agents Chemother 1998; 42: 939-41.
11. Raad I, Alrahwan A, Rolston K. Staphylococcus epidermidis: emerging resistance and need for alternative agents. Clin Infect Dis 1998; 26: 1182-7.
12. Patrick CC. Viridans streptococcal infections in patient with neutropenia. Ped Infect Dis J 1999; 18: 280-1.
13. Richard P, Amador Del Valle G, Moreau P et al. Viridans streptococcal bacteraemia in patients with neutropenia. Lancet 1995; 345: 1607-9.
14. EORTC and I. A. T. C. Group. Efficacy and toxicity of single daily doses of amikacin and ceftriaxone versus multiple daily doses of amikacin and ceftazidime for infecion in patients with cancer and granulocytopenia. Ann Intern Med 1993; 119: 584-93.
15. Cometta A, Zinner S, de Bock R et al. Piperacillintazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer. Antimicrob Agents Chemother 1995; 39: 445-52.
16. Doern GV, Ferraro MJ, Brueggemann A, Ruoff KL. Emergence of high rates of antimibrobial resistance among viridans group streptococci in the United States. Antimicrob Agents Chemother 1996; 40: 891-4.
17. Wisplinghoff U, Reinert R, Cornely O, Seifert H. Molecular relationships and antimicrobial susceptibilities of viridans group streptococci isolated from blood of neutropenic cancer patients. J Clin Microbiol 1999; 37: 1876-80.
18. Poyart C, Pierre C, Quesne G, Pron B, Berche P, Trieu-Cuot P. Emergence of vancomycin resistance in the genus Streptococcus: characterization of a vanB transferable determinant in Streptococcus bovis. Antimicrob Agents Chemother 1997; 41: 24-9.
19. Murray BE. The life and times of the Enterococcus. Clin Microbiol Rev 1990; 3: 46-65.
20. Edmond MC, Ober JF, Weinbbaum DL et al. Vancomycin-resistant Enterococcus; faecium bacteremia: risk factors for infection. Clin Infect Dis 1995; 20: 1126-33.
21. Montecalvo MA, Horowitz H, Gedric C et al. Outbreak of vancomycin-ampicillin and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit. Antimicrob Agents Chemother 1994; 38: 1363-17.
22. Arthur M, Courvalin P. Genetic and mechanisms of glycopeptide resistance in enterococci. Antimicrob Agents Chemother 1993; 37: 1563-71.
23. Noble WC, Virani Z, Cree RGA. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC12201 to Staphylococcus aureus. FEMS Microb Letters 1992; 93: 195-8.
24. Cometta A, Calandra T, Bille J, Glauser MP. 1994. Escherichia coli resistant to fluoroquinolones in patient with cancer and neutropenia. N Engl J Med 1994; 350: 1240-1.
25. Kern WV, Andriof E, Oethinger M, Kern P, Hacker J, Marre R. Emergence of fluoroquinolone-resistant Escherichia coli at a cancer center. Antimicrob Agents Chemother 1994; 38: 681-7.
26. Pena C, Albareda JM, Pallares R, Pujol M, Tubau F, Ariza J. Relationship between quinolone use and emergence of ciprofloxacin-resistant Escherichia coli in bloodstream infections. Antimicrob Agents Chemother 1995; 39: 520-4.
27. Richard P, Delangle MH, Merrien DS et al. Fluoroquinolone use and fluoroquinolone resistance: is there an association? Clin Infect Dis 1994; 19: 54-9.
28. Richard P, Delangle MH, Raffi F, Espaze E, Richet H. Impact of fluoroquinolone administration on the emergence of fluoroquinolone-resistant gram-negative bacilli from gastrointestinal flora. Clin Infect Dis 2001; 32: 162-6.
29. Flanagan NG, Kelsey PR, Whitson A, Flores B, Lewis DR, Randall M. Infection in immunonocompromised patients with malignant blood disorders in a district general hospital. J Infect 1994; 29: 1985-202.
30. Maschmeyer G, Braveny I. Review of the incidence and prognosis of Pseudmonas aeruginosa infections in cancer patients in the 1990s. Eur J Clin Microbiol Infect Dis 2000; 19: 915-25.
31. Rintala E. Incidence and clinical significance of positive blood cultures in febrile episodes of patients with hematological malignancies. Scand J Infect Dis 1994; 26: 77-84.
32. Kinnunen U, Syrjala H, Koskela M, Kujala P, Koistinen P. Continuous-monitoring blood culture screening system improves the detection of bacteremia in neutropenic patients. Scand J Infect Dis 1996; 28: 287-92.
33. Ley BE, Linton CJ, Bennett DM, Jalal H, Foot AB, Millar MR. Detection of bacteraemia in patients with fever and neutropenia using 165 rRNA gene amplification by polymerase chain reaction. Eur J Clin Microbiol Infect Dis 1998; 17: 247-53.
34. Woo PC, Wong SS, Lum PN, Hui WT, Yuen KY. Cell-wall-deficient bacteria and culture-negative febrile episodes in bone-marrow-transplant recipients. Lancet 2001; 357: 675-9.
35. Blot FG, Nitenbberg, E, Chachaty E et al. Diagnosis of catheter-related bacteremia: a prospective comparison of the time to positivity of hub-blood versus pperipheral-blood cultures. Lancet 1999; 354: 1071-7.
36. DesJardin JA, Falagas ME, Ruthazer R. Clinical utility of blood cultures drawn from undwelling central venous catheters in hospitalised patients with cancer. Ann Intern Med 1999; 131: 641-7.
37. Kite P, Dobbins BM, Wilcox MH, McMahon MJ. Rapid diagnosis of central-venous-catheter-related bloodstream infection without catheter removal. Lancet 1999; 354: 1504-7.
38. Bauer TM, Lalvani A, Fehrenbach J et al. Derivation and validation of guidelines for stool cultures for enteropathogenic bacteria other than Clostridium difficile in hospitalized adults. JAMA 2001; 285: 313-9.
39. Daw MA, Munnelly P, McCann SR, Daly PA, Falkiner FR, Keane CT. Value of surveillance cultures in the management of neutropenic patients. Eur J Clin Microbiol Infect Dis 1988; 7: 742-7.
40. Relman DA. The identification of uncultured microbial pathogens. J Infect Dis 1993; 168: 1-8.